Outpatient

17 drugs in development·15 companies·1 clinical trial

Drug Pipeline by Phase

Approved(15)

Drug	Company
atomoxetine	SUNSET ISLAND GROUP (SUN)
atomoxetine	Aptinyx Inc. (APTX)
atomoxetine	Teva Pharmaceutical Industries Limited (TEVA)
atomoxetine	DR REDDYS LABORATORIES LTD (RDY)
bupropion	SUNSET ISLAND GROUP (SUN)
bupropion	Prestige Consumer Healthcare Inc. (PBH)
bupropion	ACADIA PHARMACEUTICALS INC (ACAD)
bupropion	Design Therapeutics, Inc. (DSGN)
bupropion	Miromatrix Medical Inc. (MIRO)
buspirone	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
dextroamp saccharate	ANI PHARMACEUTICALS INC (ANIP)
enoxaparin	Amphastar Pharmaceuticals, Inc. (AMPH)
trimipramine	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
venlafaxine	Teva Pharmaceutical Industries Limited (TEVA)
Verquvo	Merck & Co., Inc. (MRK)

Phase 2(1)

Drug	Company
intranasal epinephrine technology product candidates	ARS Pharmaceuticals, Inc. (SPRY)

Phase 1(1)

Drug	Company
prulacabtagene leucel (prula-cel	Adicet Bio, Inc. (ACET)

BioSniper tracks 17 drugs in development for Outpatient across 15 companies.

There are 1 clinical trial targeting Outpatient tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.